glp-1 receptor agonist weight loss plateau strategies maintenance after discontinuation of therapies How to Break a Weight

This review synthesizes current evidence on pharmacokinetics, ...

CALMING SUPPORT FOR RESTFUL SLEEP* With GABA and other sleep-supportive ingredients, this formula encourages a calm mind and restful sleepan essential component of wellness and recovery

Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with type 2 diabetes compared with the use of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter-2 (SGLT-2) inhibitors

In this review, we summarize the state-of-the-art evidence regarding the epidemiology and pathophysiology of diabetic HFpEF, and the landscape of the novel antidiabetic drugs in the treatment of diabetic HFpEF, as well as discuss the relevant mechanisms, aiming to broaden the understanding of diabetic HFpEF and gain new insight into the treatment of this disease

Shocking Truth: Compounded GLP-1s on Groupon pose serious health risks

This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio.